Claims
- 1. A curable composition, comprising: an ethylenically unsaturated compound having more than one ethylenically unsaturated group;
- a crosslinker compound containing a multiplicity of SiH groups;
- a catalyst capable of catalyzing a hydrosilation reaction; and
- a cure-indicating dye that exhibits a color change, in a dye evaluation test, at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together,
- wherein said dye is represented by the formula ##STR38## wherein each of R.sup.48, R.sup.49, and R.sup.50, is independently selected from the group consisting of: hydrogen, halogen and an acyclic, alicyclic or aromatic hydrocarbyl group optionally interrupted with one or more heteroatoms,
- each of R.sup.51, R.sup.52, R.sup.53, R.sup.54, R.sup.55, and R.sup.56 is independently selected from the group consisting of hydrogen and an acyclic, alicyclic or aromatic hydrocarbyl group optionally interrupted with one or more heteroatoms, and optionally, any two of R.sup.51, R.sup.52, R.sup.53, R.sup.54, R.sup.55 and R.sup.56 may together form an alicyclic or aromatic ring.
- 2. The composition of claim 1, wherein each of R.sup.48, R.sup.49, and R.sup.50 is independently selected from the group consisting of hydrogen alkyl and halogen; and each R.sup.51, R.sup.52, R.sup.53, R.sup.54, R.sup.55, and R.sup.56 is independently selected from the group consisting of hydrogen and alkyl that is optionally substituted by one or more cyano, alkoxy, hydroxy, alkylsiloxy, alkylsilyl, acyl, aryl, halo, arylsiloxy, arylsilyl, amino, and mono or dialkyl amino groups.
- 3. The composition of claim 1, wherein at least one of R.sup.51, R.sup.52, R.sup.53, R.sup.54, R.sup.55, and R.sup.56 is selected from the group consisting of
- --CH.sub.2 OSi(CH.sub.3).sub.2 C(CH.sub.3).sub.3
- --CH.sub.2 OC(O)CH.sub.2 CH(CH.sub.3)CH.sub.2 C(CH.sub.3).sub.3
- --CH.sub.2 OC(O)C(CH.sub.3).sub.3
- --CH.sub.2 OCH.sub.2 OCH.sub.2 CH.sub.2 Si(CH.sub.3).sub.3
- --CH.sub.2 Cl
- --CH.sub.2 OC(O)NHCH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, and
- --CH.sub.2 OC(O)NHCH.sub.2 CH.sub.2 CH.sub.2 Si(OCH.sub.2 CH.sub.3).sub.3.
- 4. A curable composition, comprising:
- an ethylenically unsaturated compound having more than one ethylenically unsaturated group;
- a crosslinker compound containing a multiplicity of SiH groups;
- a catalyst capable of catalyzing a hydrosilation reaction; and a cure-indicating dye that exhibits a color change in a dye evaluation test, at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together,
- wherein said dye is represented by the formula ##STR39## wherein X.sup.4 is N--R.sup.67 R.sup.68, O--R.sup.69, S--R.sup.70 or CR.sup.71 R.sup.72 R.sup.73 and wherein each of R.sup.58, R.sup.59, R.sup.60, R.sup.61, R.sup.62, R.sup.63, R.sup.64, R.sup.65, R.sup.66, is independently selected from the group consisting of hydrogen, halogen, a hydrocarbyl group optionally interrupted with one or more heteroatoms and an acyclic, alicyclic or aromatic heterocyclic group, and each of R.sup.67, R.sup.68, R.sup.69, R.sup.70, R.sup.71, R.sup.72, and R.sup.73 is independently selected from the group consisting of hydrogen, a hydrocarbyl group optionally interrupted with one or more heteroatoms and an acyclic, alicyclic or aromatic heterocyclic group.
- 5. The composition of claim 4, wherein each or R.sup.67, R.sup.68, R.sup.69, R.sup.70, R.sup.71, R.sup.72, and R.sup.73 is independently selected from the group consisting of hydrogen and alkyl that is optionally substituted by one or more cyano, alkoxy, hydroxy, alkylsiloxy, alkylsilyl, acyl, aryl, halo, arylsiloxy, arylsilyl, amino, and mono or dialkyl amino groups.
- 6. The composition of claim 4, wherein at least one of R.sup.67, R.sup.68, R.sup.69, R.sup.70, R.sup.71, R.sup.72, and R.sup.73 is selected from the group consisting of
- --CH.sub.2 CH.sub.2 OSi(CH.sub.3).sub.2 C(CH.sub.3).sub.3
- --CH.sub.2 CH.sub.2 OC(O)CH.sub.2 CH(CH.sub.3)CH.sub.2 C(CH.sub.3).sub.3
- --CH.sub.2 CH.sub.2 OC(O)C(CH.sub.3).sub.3
- --CH.sub.2 CH.sub.2 OCH.sub.2 OCH.sub.2 CH.sub.2 Si(CH.sub.3).sub.3
- --CH.sub.2 CH.sub.2 Cl
- --CH.sub.2 CH.sub.2 OC(O)NHCH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, and
- --CH.sub.2 CH.sub.2 OC(O)NHCH.sub.2 CH.sub.2 CH.sub.2 Si(OCH.sub.2 CH.sub.3).sub.3.
- 7. A curable composition, comprising:
- an ethylenically unsaturated compound having more than one ethylenically unsaturated group;
- a crosslinker compound containing a multiplicity of SiH groups;
- a catalyst capable of catalyzing a hydrosilation reaction; and
- a cure-indicating dye that exhibits a color change in a dye evaluation test, at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together, wherein said dye is selected from compounds of the formula ##STR40##
- 8. A curable composition, comprising:
- a compound having more than one ethylenically unsaturated group;
- a crosslinker compound containing a multiplicity of SiH groups;
- a catalyst capable of catalyzing a hydrosilation reaction; and
- a cure-indicating dye that exhibits a color change, in a dye evaluation test, at 25.degree. C. when 500 .mu.g of said dye, about 500 .mu.l of dichloromethane, 100 .mu.l of pentamethyldisiloxane, and 10 .mu.l of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together.
- 9. A curable composition according to claim 8, wherein said compound having more than one ethylenically unsaturated group is aliphatic and comprises olefinic or acetylenic unsaturation.
- 10. A curable composition according to claim 8, wherein said compound having more than one ethylenically unsaturated group comprises a silicone backbone and at least two functional groups selected from the group consisting of vinyl, allyl, butenyl, propenyl, isopropenyl, hexenyl, cyclohexenyl, cyclopentyl, cycloheptenyl and cyclooctenyl groups.
- 11. A curable composition according to claim 8, wherein said compound having more than one ethylenically unsaturated group has a weight average molecular weight between 4,000 and 150,000.
- 12. A curable composition according to claim 8, wherein said crosslinker compound comprises at least two SiH groups selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched organohydropolysiloxanes.
- 13. A curable composition according to claim 8, wherein said composition comprises a ratio of SiH groups to functional groups between 1:1 and 10:1.
- 14. A curable composition according to claim 8, wherein said catalyst is selected from the group consisting of: chloroplatinic acid; a complex of chloroplatinic acid and an alcohol; a complex of platinum and an olefin; a complex of platinum and a ketone; a complex of platinum and a vinylsiloxane; colloidal platinum, a complex of colloidal platinum and a vinylsiloxane; tetrakis (triphenylphosphine) palladium; a mixture of palladium black and triphenylphosphine; rhodium or rhodium compound catalysts; radiation activated hydrosilation catalysts including (h.sup.4 -cyclooctadiene)diarylplatinum complexes; (h.sup.5 -cyclopentadienyl)trialkylplatinum complexes, and (h.sup.5 -cyclopentadienyl)tri(s-aliphatic)-platinum complexes with a sensitizer that is capable of absorbing visible light; and Platinum(II) b-diketonate complexes.
- 15. A curable composition according to claim 8, wherein said catalyst comprises platinum and wherein said composition comprises a ratio of platinum to functional groups between 1:2 and 1:1,000.
- 16. A curable composition according to claim 8, wherein said catalyst is a Karsted catalyst, wherein said composition comprises a ratio of platinum to functional groups between 1:2 and 1:1,000, and wherein said compound having more than one ethylenically unsaturated group comprises a silicone backbone having two or more vinyl functional groups.
- 17. A curable composition according to claim 8, wherein said cure-indicating dye has a first color in the visible spectrum before the cure reaction is effected and is essentially colorless after the cure reaction is effected.
- 18. A curable composition according to claim 8, wherein said cure-indicating dye changes color to indicate the gel point of said composition.
- 19. A curable composition according to claim 10, wherein said cure-indicating dye changes color to indicate the set time of said composition.
- 20. A curable composition according to claim 8, wherein said cure-indicating dye changes color to indicate that the composition has finished evolving gas as a result of being cured.
- 21. A curable composition according to claim 8, wherein said composition further comprises an additional cure-indicating dye that exhibits a color change, in a dye evaluation test, at 25.degree. C. when 500 .mu.g of said dye, about 500 .mu.l of dichloromethane, 100 .mu.l of pentamethyldisiloxane, and 10 .mu.l of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together.
- 22. A curable composition according to claim 8, wherein said cure-indicating dye is present in an amount at least 0.0001 weight percent.
- 23. A curable composition according to claim 8, wherein said cure-indicating dye has a molar extinction coefficient of at least 10,000M.sup.-1 cm.sup.-1.
- 24. A curable composition according to claim 10, wherein said cure-indicating dye exhibits a loss of 90% in absorbance within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together as compared to an identical solution that does not contain a hydrosilation catalyst.
- 25. A curable composition according to claim 8, wherein said cure-indicating dye exhibits a loss of 99% in absorbance within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together as compared to an identical solution that does not contain a hydrosilation catalyst.
- 26. A curable composition according to claim 16, wherein said cure-indicating dye exhibits a transition time between the onset of color change and the effective completion of the color change of less than three minutes at 32.degree. C.
- 27. A curable composition according to claim 10, wherein said cure-indicating dye is selected from the group consisting of indoaniline dyes, indophenol dyes, quinone monoimine dyes, quinone diimine dyes, cyanine dyes, merocyanine dyes, cyclohexadienone dyes, iminocyclohexadienone dyes, imidazolylidinecyclohexadienone dyes, dihydronaphthalenone dyes, iminodihydronaphthalenone dyes, imidazolylidinedihydronaphthalenone dyes, cyclohexadienimine dyes, aryl substituted bis trifluoromethylsulfonylhexatrienyl dyes, aryl substituted bis (trifluoromethylsulfonyl)butadienyl dyes, aryl substituted bis (fluorosulfonyl)hexatrienyl dyes, aryl substituted bis (fluorosulfonyl)butadienyl dyes, oxazolone dyes, cationic dyes, anionic dyes and amphoteric dyes.
- 28. A curable composition according to claim 8, wherein said cure-indicating dye is selected from the group consisting of: 4-[[4-(Dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 4-[[4-(Diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[4-(Dimethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[2-methyl-4-(diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 3-Methoxy-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Methyl-4-[[4-(4-morpholinyl)phenyl]-imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[4-(4-morpholinyl)-phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dimethyl-4-[[4-(4-morpholinyl)-phenyl]imino]-2,5-cyclohexadien-1-one; 2,5-Dichloro-4-[[4-(diethylamino)-phenyl]imino]-2,5-cyclohexadien-1-one; 3-Methoxy-4-[[3-methoxy-4-(diethyl-amino)phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo-N-phenyl-1,4-cyclohexadiene-1-carboxamide; 5-[[4-(Diethylamino)-2-methylphenyl]imino]-8-(5H)-quinolinone; 2,5-Dichloro-4-[[2-methyl-4-(diethylamino)-phenyl]imino]-2,5-cyclohexadiene-1-one; 2,6-Dichloro-4-[[4-(acetamido)phenyl]imino]-2,5-cyclohexadiene-1-one; 2,6-Dichloro-4-[4-ethoxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(2-methyl-4-ethoxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dimethyl-4-[4-hydroxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(4-methoxy-1-naphthyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[4-(benzyloxy)phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(2,4-dimethoxyphenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(4-methoxyphenyl)imino]-2,5-cyclohexadien-1-one; 4-(phenylimino)-2,5-cyclohexadien-1-one; 4-(1-naphthylimino)-2,5-cyclohexadien-1-one; 4-(2-naphthylimino)-2,5-cyclohexadien-1-one; 2,5-Bis(phenylamino)-4(phenylimino)-2,5-cyclohexadien-1-one; 2,5-Dibromo-4-[(2,4-dibromophenyl)imino]-2,5-cyclohexadien-1-one; 2,3,5-Trichloro-4-[(2,4,6-trichlorophenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[4-[4-(dimethylamino)phenyl]-5-phenyl-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[4,5-bis(4-hydroxyphenyl)-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Dimethoxy-4-[4,5-bis(2-furyl)-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Bis[1,1-(dimethyl)ethyl]-4-[4,5-bis(2-furyl)-(2H)-imidazol-2-ylidene]-2,5-cyclohexadien-1-one; 4-(phenylimino)-2,5-cyclohexadien-1-imine; Mono[(3-methyl-2-(3H)-benzothiazolylidene)hydrazono]2,5-cyclohexadiene-1,4-dione; 4-[(3-Chloro-4-oxo-2,5-cyclohexadien-1-ylidine)-amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-(3H)-pyrazol-3-one; 4-[(3,5-Dichloro-4-oxo-2,5-cyclohexadiene-1-ylidine)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-(3H)-pyrazol-3-one; 3-[(3,5-Dichloro-4-oxo-2,5-cyclohexadien-1-ylidine)amino]-2,5-dihydro-4,5-dimethyl-1-phenylpyrrol-2-one; 4-(Phenylsulfonyl)imino-1-[4-[(phenylsulfonyl)imino]-2,5-cyclohexadien-1-ylidenyl]-2,5-cyclohexadiene; 4-[6,6-Bis[(trifluoromethyl)sulfonyl]-1,3,5-hexatrienyl]-N,N-dimethylbenzenamine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2-ethoxy-N,N-dimethylbenzenamine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,5-dimethoxy-N,N-dimethylbenzenamine; 9-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,3,6,7-tetrahydro-(1H,5H)-benzo[ij]quinolizine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,6-N,N-tetramethyl-benzenamine; 4-[5,5-Bis[(trifluoromethyl)sulfonyl]-2,4-pentadienylidene]-1,4-dihydro-1-methylquinoline; 6,6-Bis[4-(dimethylamino)phenyl]1,3,5-hexatriene-1,1-bis(sulfonylfluoride); 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-N,N-dimethylbenzenamine; and 4-[3-[4-(Dimethylamino)phenyl]-2-propenylidene]-2-phenyl-5(4H)-oxazolone; anionic dyes having the following anions: 5-[5-(1,3-Diethylhexahydro-2,4,6-trioxo-5-pyrimidinyl)-2,4-pentadienylidene]-1,3-diethyl-2,4,6(1H,3H,5H)-pyrimidenetrione; and cationic dyes having the following cations or having the cations of the following cationic dyes: 3H-Indolium, 3-[3-[4-(dimethylamino)phenyl]-2-propenylidene]-1-methyl-2-phenyl; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-[bis(2-chloroethyl)amino]phenyl]azo]-6-methoxy-; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-(diethylamino)phenyl]azo]-6-ethoxy-; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-(diethylamino)-2-methylphenyl]azo]-6-ethoxy-; C. I. Basic Blue 68; C. I. Basic Blue 76; C. I. Basic Blue 57; C. I. Basic Blue 60; Benzo[a]phenoxazin-7-ium, 9-(dimethylamino)-; 2-[4,4,-bis[4-dimethylamino)phenyl]-1,3-butadienyl]-1-ethyl quinolinium; 4-[4,4,-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]1-ethyl quinolinium; Naphtho[2,1-d]thiazolium, 2-[4,4-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]-3-ethyl-; 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-phenyl-3-methyl quinoxalinium; Quinolinium, 2-[3-(5-chloro-1,3-dihydro-1,3,3-trimethyl-(2H)-indol-2-ylidene)-1-propenyl]-1-methyl-; Benzothiazolium, 2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methyl-; Benz[cd]indolium, 2-[4-(diethylamino)-2-ethoxyphenyl]-1-ethyl-; 2-[p-(Dimethylamino)styryl]-1,3-dimethylquinoxalinium; 2-[3-(5-chloro-1,3-dihydro-1,3,3-trimethyl-(2H)-indol-2-ylidene)-1-propenyl]-1-methylquinoxalinium; C. I. Basic Blue 40; Benzothiazolium, 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methyl-; Benzothiazolium, 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methyl-; C. I. Basic Blue 42; C. I. Basic Blue 53; 3H-Indolium, 5-chloro-2-[5-(5-chloro-1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1,3-pentadienyl]-1,3,3-trimethyl-; Basic Blue 142; Benz[cd]indolium, 2-[2-(9-ethyl-(9H)-carbazol-3-yl)ethenyl]-1-methyl-; Benz[cd]indolium, 2-[2-[4-(dimethylamino)phenyl]-2-phenylethenyl]-1-methyl-; Benz[cd]indolium, 2-[2,2-bis[4-(dimethylamino)phenyl]ethenyl]-1-methyl-; Benz[cd]indolium, 2-[2-(2,3-dihydro-1-methyl-2-phenyl-1H-indol-3-yl)-2-(2-methylphenyl)ethenyl]-1-methyl-; Pyrimidinium, 4-[5-(2,3-dihydro-1,3-dimethyl-2-oxo-; 4(1H)-pyrimidinylidene)-1,3-pentadienyl]-2,3-dihydro-1,3-dimethyl-2-oxo-; 3H-Indolium, 2-[[3-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)methyl]-5,5-dimethyl-2-cyclohexen-1-ylidene]methyl]-1,3,3-trimethyl-; Benz[cd]indolium, 2-[2-[4-(diethylamino)-2-methylphenyl]ethenyl]-1-methyl-; 3H-Indolium, 3-[3-[4-[(dimethylamino)phenyl]-2-propenylidene]-1-methyl-2-(4-methoxyphenyl)-; 3H-Indolium, 3-[(2,5-dimethyl-1-phenyl-(1H)-pyrrol-3-yl)methylene]-1,2-dimethyl-; 3H-Indolium, 3-[2,5-dimethyl-1-phenyl-(1H)-pyrrol-3-yl)methylene]-1-methyl-2-phenyl-; 2-[2-[2-chloro-4-(dimethylamino)phenyl]ethenyl]-1-methylbenz[cd]indolium; C. I. Basic Violet 22; C. I. Basic Red 15; Benz[cd]indolium, 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-; Benz[cd]indolium,2-[2-[4-(dimethylamino)-2-ethoxyphenyl]ethenyl]-1-methyl-; and 3H-Indolium, 2-[1-cyano-4,4-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]-1,3,3-trimethyl-.
- 29. A curable composition according to claim 8, wherein said cure-indicating dye is selected from the group consisting of: neutral dyes represented by the following general formula: ##STR41## wherein: each R.sup.1, R.sup.2, R.sup.3, and R.sup.4 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein R.sup.1 and R.sup.2 or R.sup.3 and R.sup.4 may be connected to form a saturated or unsaturated ring;
- A is O, S, or NR.sup.22, wherein
- R.sup.22 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group; and
- B is any group capable of providing extended conjugation thereby rendering the dye capable of absorbing visible, near-UV, or near-infrared radiation including groups of formula D, E, F, H, or J, wherein
- D is represented by formula: ##STR42## wherein: each R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 groups may be connected to form a ring;
- E is represented by formula: ##STR43## wherein: X.sup.1 is C(R.sup.12).sub.2, S, NR.sup.12, or O;
- X.sup.2 is C(R.sup.12).sub.2, S, NR.sup.12, or O; and
- each R.sup.10, R.sup.11 and R.sup.12 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein R.sup.10 and R.sup.11 may be connected to form a ring;
- F is represented by formula: ##STR44## wherein: X.sup.3 is N or CR.sup.16 ; and
- each R.sup.13, R.sup.14, R.sup.15, and R.sup.16 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.13, R.sup.14, R.sup.15, and R.sup.16 groups may be connected to form a ring;
- H is represented by formula: ##STR45## wherein: each R.sup.20 and R.sup.21 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein R.sup.20 and R.sup.21 may be connected to form a ring; and
- J is represented by formula: ##STR46## wherein: each R.sup.5, R.sup.6, R.sup.7 and R.sup.8 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two R.sup.5, R.sup.6, R.sup.7 and R.sup.8 groups may be connected to form a ring; and
- R.sup.23 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group;
- sulfonyl dyes represented by the following general formula: ##STR47## wherein: each R.sup.24 and R.sup.25 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group with the proviso that at least one of R.sup.24 and R.sup.25 is or contains a substituted aryl, aminoaryl or heterocyclic group;
- each R.sup.26 and R.sup.27 group is independently a --(CF.sub.2).sub.m F group wherein m is a number between 0 and 20; and
- n is an integer less than 5;
- neutral dyes represented by the following general formula: ##STR48## wherein: each R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.29 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.1, R.sup.2, R.sup.3, R.sup.4, or R.sup.29 groups may be connected to form a ring; and
- R.sup.30 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and n is an integer less than 5;
- anionic dyes having the following general formula: ##STR49## wherein: Z represents the non-metallic atoms necessary to complete a substituted or unsubstituted nitrogen-containing heterocyclic ring;
- each R.sup.28 is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group;
- n is an integer less than 5; and wherein
- M+ is selected from any suitable cation;
- cationic dyes having the following general formula: ##STR50## wherein: each R.sup.31, R.sup.32, R.sup.33, and R.sup.34 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- R.sup.35 and R.sup.36 are as defined above for R.sup.33 and R.sup.34 ;
- X is O, S, or NR.sup.37 ;
- Y is N or CR.sup.38 ;
- R.sup.37 and R.sup.38 are as defined above for R.sup.33 ; and wherein
- M- is any suitable anion;
- cationic dyes having the following general formula: ##STR51## wherein: each R.sup.31, R.sup.32, R.sup.33, R.sup.34 and R.sup.40 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- R.sup.39 is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group;
- X is C.dbd.R.sup.48, C(R.sup.38).sub.2, O, S, or NR.sup.37, wherein
- R.sup.37 is as defined above for R.sup.39,
- R.sup.38 is as defined above for R.sup.40,
- R.sup.48 is an oxo group, a divalent hydrocarbyl-containing group or a divalent heterocyclic group, and wherein R.sup.48 and R.sup.34 may be connected to form an unsaturated ring, and R.sup.37 and R.sup.34 may be connected to form a ring; and wherein
- M- is any suitable anion; and
- cationic dyes having the following general formula: ##STR52## wherein: each R.sup.42 to R.sup.47 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group;
- each R.sup.40, R.sup.41, R.sup.46, and R.sup.47 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.41 to R.sup.43 and R.sup.44 to R.sup.46 groups may form a ring;
- n is an integer less than 5; and wherein
- M- is any suitable anion.
- 30. A curable composition according to claim 8, wherein said cure-indicating dye is selected from the group consisting of 4-[[4-(Dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 4-[[4-(Diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[4-(Dimethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[2-methyl-4-(diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 3-Methoxy-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Methyl-4-[[4-(4-morpholinyl)phenyl]imino]-2,5-cyclohexadien-1-one; 2,5-Dichloro-4-[[4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo-N-phenyl-1,4-cyclohexadiene-1-carboxamide; 5-[[4-(Diethylamino)-2-methylphenyl]imino]-8-(5H)-quinolinone; 2,6-Dichloro-4-[[4-(acetamido)phenyl]imino]-2,5-cyclohexadien-1-one; 4-(1-naphthylimino)-2,5-cyclohexadien-1-one; 4-(2-naphthylimino)-2,5-cyclohexadien-1-one; 2,5-Bis(phenylamino)-4(phenylimino)-2,5-cyclohexadien-1-one; 4-[5,5-Bis[(trifluoromethyl)sulfonyl]-2,4-pentadienylidene]-1,4-dihydro-1-methylquinoline; 6,6-Bis[4-(dimethylamino)phenyl]1,3,5-hexatriene-1,1-bis(sulfonylfluoride); 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-N,N-dimethylbenzenamine; and 4-[3-[4-(Dimethylamino)phenyl]-2-propenylidene]-2-phenyl-5(4H)-oxazolone.
- 31. A curable composition according to claim 8, wherein said composition is in the form of a coating on a substrate.
- 32. A curable composition according to claim 8, wherein said composition exhibits a color change upon curing of at least 10 .DELTA.E* units.
- 33. A curable composition, comprising:
- an ethylenic compound comprising a silicone backbone having two or more vinyl functional groups;
- a crosslinker compound comprising at least two SiH groups and being selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched organohydropolysiloxanes;
- a catalyst capable of catalyzing a hydrosilation reaction, wherein said catalyst comprises a complex of platinum and a vinylsiloxane and wherein said composition comprises a molar ratio of platinum to vinyl functional groups between 1:2 and 1:1,000; and
- a cure-indicating dye that exhibits a color change within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together, wherein said cure-indicating dye is selected from the group consisting of indoaniline dyes, indophenol dyes, quinone monoimine dyes, quinone diimine dyes, cyanine dyes, merocyanine dyes, cyclohexadieneone dyes, iminocyclohexadieneone dyes, imidazolylidinecyclohexadienone dyes, dihydronaphthalenone dyes, iminodihydronaphthalenone dyes, imidazolylidinedihydronaphthalenone dyes, cyclohexadienimine dyes, aryl substituted bis (trifluoromethylsulf-onyl)hexatrienyl dyes, aryl substituted bis (trifluoromethylsulfonyl)butadienyl dyes, aryl substituted bis (fluorosulfonyl)hexatrienyl dyes, aryl substituted bis (fluorosulfonyl)butadienyl dyes, oxazolone dyes, cationic dyes, anionic oxonol dyes and betaine dyes.
- 34. A curable composition, comprising:
- an ethylenic compound comprising a silicone backbone having two or more vinyl functional groups;
- a crosslinker compound comprising at least two SiH groups and being selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched organohydropolysiloxanes;
- a catalyst capable of catalyzing a hydrosilation reaction, wherein said catalyst comprises platinum and wherein said composition comprises a molar ratio of platinum to functional groups between 1:2 and 1:1,000; and
- a cure-indicating dye that exhibits a color change within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together, wherein said cure-indicating dye is selected from the group consisting of: neutral dyes represented by the following general formula: ##STR53## wherein: each R.sup.1, R.sup.2, R.sup.3, and R.sup.4 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, carboxamide (--C(O)NR.sup.1 R.sup.2), and wherein R.sup.1 and R.sup.2 or R.sup.3 and R.sup.4 may be connected to form a ring;
- A is O or NR.sup.22, wherein
- R.sup.22 is a group selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.6 -C.sub.18 arylamino, and substituted sulfonyl; and
- B is any group capable of providing extended conjugation thereby rendering the dye capable of absorbing visible, near-UV, or near-infrared radiation including groups of formula D, E, F, H, or J, wherein
- D is represented by formula: ##STR54## wherein: each R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, morpholino, and alkylamido and wherein any two adjacent R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 groups may be connected to form a ring;
- E is represented by formula: ##STR55## wherein: X.sup.1 is S or O;
- X.sup.2 is C(R.sup.12).sub.2 or NR.sup.12 ; and
- each R.sup.10, R.sup.11 and R.sup.12 group is independently selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, and wherein R.sup.10 and R.sup.11 may be connected to form a ring;
- F is represented by formula: ##STR56## wherein: X.sup.3 is N or CR.sup.16 ; and
- each R.sup.13, R.sup.14, R.sup.15, and R.sup.16 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino and wherein any two adjacent R.sup.13, R.sup.14, R.sup.15, and R.sup.16 groups may be connected to form a ring;
- H is represented by formula: ##STR57## wherein: each R.sup.20 and R.sup.21 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, morpholino, and furyl and wherein R.sup.20 and R.sup.21 may be connected to form a ring; and
- J is represented by formula: ##STR58## wherein: each R.sup.5, R.sup.6, R.sup.7 and R.sup.8 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, morpholino, alkylamido and wherein R.sup.5 and R.sup.6 or R.sup.7 and R.sup.8 may be connected to form a ring; and
- R.sup.23 is a group selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.8 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, and substituted sulfonyl;
- sulfonyl dyes represented by the following general formula: ##STR59## wherein: each R.sup.24 and R.sup.25 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino with the proviso that at least one of R.sup.24 and R.sup.25 is or contains a substituted aryl, aminoaryl or heterocyclic group;
- each R.sup.26 and R.sup.27 group is independently selected from the group consisting of: F and CF.sub.3 ; and
- n is 0 to 3;
- neutral dyes represented by the following general formula: ##STR60## wherein: each R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.29 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.8 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, carboxamide (--C(O)NR.sup.1 R.sup.2), and wherein any two adjacent R.sup.1, R.sup.2, R.sup.3, R.sup.4, or R.sup.29 groups may be connected to form a ring;
- R.sup.30 is a group selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino; and
- n is 1 or 2;
- anionic oxonol dyes having the following general formula: ##STR61## wherein: Z represents the non-metallic atoms necessary to complete a substituted or unsubstituted nitrogen-containing heterocyclic ring,
- each R.sup.28 is independently selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.6 -C.sub.18 aminoaryl;
- n is 1 or 2; and wherein
- M+ is selected from any suitable cation;
- cationic dyes having the following general formula: ##STR62## wherein: each R.sup.31, R.sup.32, R.sup.33, and R.sup.34 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, carboxamide (--C(O)NR.sup.1 R.sup.2), and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- R.sup.35 and R.sup.36 are as defined above for R.sup.33 and R.sup.34 ;
- X is O or NR.sup.37 ;
- Y is N or CR.sup.38 ;
- R.sup.37 and R.sup.38 are as defined above for R.sup.33 ; and wherein
- M- is any suitable anion;
- cationic dyes having the following general formula: ##STR63## wherein: each R.sup.31, R.sup.32, R.sup.33, and R.sup.34 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, carboxamide (--C(O)NR.sup.1 R.sup.2), and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- each R.sup.39 is independently selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino;
- R.sup.40 is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino, and carboxamide;
- X is C.dbd.R.sup.48, C(R.sup.38).sub.2 or S, wherein
- R.sup.38 is as defined above for R.sup.40 ;
- R.sup.48 is an oxo group, a divalent hydrocarbyl-containing group, or a divalent heterocyclic group; and wherein R.sup.48 and R.sup.34 may be connected to form an unsaturated ring; and wherein
- M- is any suitable anion;
- cationic dyes having the following general formula: ##STR64## wherein: each R.sup.42 to R.sup.45 group is independently selected from the group consisting of: hydrogen, halogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.1 -C.sub.20 alkoxy, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino;
- each R.sup.40, R.sup.41, R.sup.46 and R.sup.47 group is independently selected from the group consisting of: hydrogen, a C.sub.1 -C.sub.20 alkyl, a C.sub.3 -C.sub.18 cycloalkyl, a C.sub.6 -C.sub.18 aryl, a C.sub.6 -C.sub.18 aryloxy, a C.sub.6 -C.sub.18 hydroxyaryl, a C.sub.6 -C.sub.18 arylcarboxy, a C.sub.6 -C.sub.18 carboxyaryl, a C.sub.2 -C.sub.18 alkenyl, a C.sub.1 -C.sub.20 alkylamino, a C.sub.6 -C.sub.18 arylamino, a C.sub.6 -C.sub.18 aminoaryl, a C.sub.2 -C.sub.20 di(hydrocarbyl)amino and wherein any two adjacent R.sup.41 to R.sup.43 and R.sup.44 to R.sup.46 groups may be connected to form a ring;
- n is 1 or 2; and wherein
- M- is any suitable anion.
- 35. A curable composition, comprising:
- an ethylenic compound comprising a silicone backbone having two or more vinyl functional groups;
- a crosslinker compound comprising at least two SiH groups and being selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched organohydropolysiloxanes, wherein said composition comprises a ratio of SiH groups to functional groups between 1:1 and 10:1;
- a catalyst capable of catalyzing a hydrosilation reaction, wherein said catalyst comprises platinum and wherein said composition comprises a ratio of platinum to functional groups between 1:2 and 1:1,000; and
- a cure-indicating dye selected from the group consisting of 4-[[4-(Dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 4-[[4-(Diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[4-(Dimethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[2-methyl-4-(diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 3-Methoxy-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Methyl-4-[[4-(4-morpholinyl)phenyl]imino]-2,5-cyclohexadien-1-one; 2,5-Dichloro-4-[[4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo-N-phenyl-1,4-cyclohexadiene-1-carboxamide; 5-[[4-(Diethylamino)-2-methylphenyl]imino]-8-(5H)-quinolinone; 2,6-Dichloro-4-[[4-(acetamido)phenyl]imino]-2,5-cyclohexadien-1-one; 4-(1-naphthylimino)-2,5-cyclohexadien-1-one; 4-(2-naphthylimino)-2,5-cyclohexadien-1-one; 2,5-Bis(phenylamino)-4(phenylimino)-2,5-cyclohexadien-1-one; 4-[5,5-Bis[(trifluoromethyl)sulfonyl]-2,4-pentadienylidene]-1,4-dihydro-1-methylquinoline; 6,6-Bis[4-(dimethylamino)phenyl]1,3,5-hexatriene-1,1-bis(sulfonylfluoride); 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-N,N-dimethylbenzenamine; and 4-[3-[4-(Dimethylamino)phenyl]-2-propenylidene]-2-phenyl-5(4H)-oxazolone.
- 36. A silicone composition comprising:
- a curable silicone polymer containing at least two functional groups capable of reacting with a SiH group in the presence of a catalyst;
- a crosslinker compound containing at least two SiH groups;
- a hydrosilation catalyst; and
- one or more cure-indicating dyes that exhibit a color change within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together.
- 37. A silicone composition according to claim 36, wherein said curable silicone polymer comprises vinyl functional groups.
- 38. A silicone composition according to claim 37, wherein said curable silicone polymer has a weight average molecular weight between 1,000 and 450,000.
- 39. A silicone composition according to claim 36, wherein said curable silicone polymer has a weight average molecular weight between 4,000 and 150,000.
- 40. A silicone composition according to claim 37, wherein said curable silicone polymer has the formula: ##STR65## wherein R.sup.1 and R.sup.2 are vinyl and n has a value between about 50 and 2,000.
- 41. A silicone composition according to claim 36, wherein said curable silicone polymer has the formula: ##STR66## wherein at least two but not more than one-half of all the R.sup.1 groups in said polymer comprise a functional group selected from the group consisting of vinyl, allyl, butenyl, propenyl, isopropenyl, hexenyl, cyclohexenyl, cyclopentyl, cycloheptenyl and cyclooctenyl groups, and the remainder of said R.sup.1 groups comprise a group that will not react with SiH compounds in the presence of a catalyst; and wherein m represents 0, 1, 2, or 3, and n represents a number having an average value from 1 to about 10,000.
- 42. A silicone composition according to claim 39, wherein said crosslinker compound is selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched polyorganohydropolysiloxanes.
- 43. A silicone composition according to claim 37, wherein said composition comprises a ratio of SiH groups to functional groups between 1.3:1 and 4:1.
- 44. A silicone composition according to claim 37, wherein said hydrosilation catalyst is selected from the group consisting of: chloroplatinic acid, a complex of chloroplatinic acid and an alcohol, a complex of platinum and an olefin, a complex of platinum and a ketone, a complex of platinum and a vinylsiloxane, colloidal platinum, a complex of colloidal platinum and a vinylsiloxane; tetrakis (triphenylphosphine) palladium, a mixture of palladium black and triphenylphosphine; rhodium or rhodium compound catalysts; radiation activated hydrosilation catalysts including (h.sup.4 -cyclooctadiene)diarylplatinum complexes, (h.sup.5 -cyclopentadienyl)trialkylplatinum complexes, and (h.sup.5 -cyclopentadienyl)tri(s-aliphatic)-platinum complexes with a sensitizer that is capable of absorbing visible light; and Pt(II) B-diketonate complexes.
- 45. A silicone composition according to claim 44, wherein said hydrosilation catalyst comprises platinum and wherein said composition comprises a ratio of platinum to functional groups between 1:2 and 1:1,000.
- 46. A silicone composition according to claim 43, wherein said hydrosilation catalyst comprises a Karstedt catalyst.
- 47. A silicone composition according to claim 36, wherein said composition has a first color in the visible spectrum before the cure reaction is effected and a second different color after the cure reaction is effected.
- 48. A silicone composition according to claim 47, wherein the difference between said first color and said second color is visible to the naked eye.
- 49. A silicone composition according to claim 47, wherein the difference between said first color and said second color is detectable by the human eye when referenced to an external color standard which matches either said first or said second color.
- 50. A silicone composition according to claim 46, wherein said cure-indicating dye changes color to indicate the gel point of said composition.
- 51. A silicone composition according to claim 46, wherein said cure-indicating dye changes color to indicate the set time of said composition.
- 52. A silicone composition according to claim 36, wherein said composition further comprises an additional cure-indicating dye.
- 53. A silicone composition according to claim 43, wherein said cure-indicating dye is present in an amount at least 0.0001 weight percent.
- 54. A silicone composition according to claim 36, wherein said cure-indicating dye has a molar extinction coefficient of at least 10,000 M.sup.-1 cm.sup.-1.
- 55. A silicone composition according to claim 36, wherein said cure-indicating dye is selected from the group consisting of indoaniline dyes, indophenol dyes, quinone monoimine dyes, quinone diimine dyes, cyanine dyes, merocyanine dyes, cyclohexadienone dyes, iminocyclohexadienone dyes, imidazolylidinecyclohexadienone dyes, dihydronaphthalenone dyes, iminodihydronaphthalenone dyes, imidazolylidinedihydronaphthalenone dyes, cyclohexadienimine dyes, aryl substituted bis trifluoromethylsulfonylhexatrienyl dyes, aryl substituted bis (trifluoromethylsulfonyl)butadienyl dyes, aryl substituted bis (fluorosulfonyl)hexatrienyl dyes, aryl substituted bis (fluorosulfonyl)butadienyl dyes, oxazolone dyes, cationic dyes, anionic dyes and amphoteric dyes.
- 56. A silicone composition according to claim 36, wherein said cure-indicating dye is selected from the group consisting of: neutral dyes represented by the following general formula: ##STR67## wherein: each R.sup.1, R.sup.2, R.sup.3, and R.sup.4 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein R.sup.1 and R.sup.2 or R.sup.3 and R.sup.4 may be connected to form a saturated or unsaturated ring;
- A is O, S, or NR.sup.22, wherein
- R.sup.22 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group; and
- B is any group capable of providing extended conjugation thereby rendering the dye capable of absorbing visible, near-UV, or near-infrared radiation including groups of formula D, E, F, H, or J, wherein
- D is represented by formula: ##STR68## wherein: each R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 groups may be connected to form a ring;
- E is represented by formula: ##STR69## wherein: X.sup.1 is C(R.sup.12).sub.2, S, NR.sup.12, or O;
- X.sup.2 is C(R.sup.12).sub.2, S, NR.sup.12, or O; and
- each R.sup.10, R.sup.11 and R.sup.12 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein R.sup.10 and R.sup.11 may be connected to form a ring;
- F is represented by formula: ##STR70## wherein: X.sup.3 is N or CR.sup.16 ; and
- each R.sup.13, R.sup.14, R.sup.15, and R.sup.16 group is independently hydrogen halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.13, R.sup.14, R.sup.15, and R.sup.16 groups may be connected to form a ring;
- H is represented by formula: ##STR71## wherein: each R.sup.20 and R.sup.21 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein R.sup.20 and R.sup.21 may be connected to form a ring; and
- J is represented by formula: ##STR72## wherein: each R.sup.5, R.sup.6, R.sup.7 and R.sup.8 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two R.sup.5, R.sup.6, R.sup.7 and R.sup.8 groups may be connected to form a ring; and
- R.sup.23 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group;
- sulfonyl dyes represented by the following general formula: ##STR73## wherein: each R.sup.24 and R.sup.25 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group with the proviso that at least one of R.sup.24 and R.sup.25 is or contains a substituted aryl, aminoaryl or heterocyclic group;
- each R.sup.26 and R.sup.27 group is independently a --(CF.sub.2).sub.m F group wherein m is a number between 0 and 20; and
- n is an integer less than 5;
- neutral dyes represented by the following general formula: ##STR74## wherein: each R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.29 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.1, R.sup.2, R.sup.3, R.sup.4, or R.sup.29 groups may be connected to form a ring; and
- R.sup.30 is hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group and n is an integer less than 5;
- anionic dyes having the following general formula: ##STR75## wherein: Z represents the non-metallic atoms necessary to complete a substituted or unsubstituted nitrogen-containing heterocyclic ring;
- each R.sup.28 is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group;
- n is an integer less than 5; and wherein
- M+ is selected from any suitable cation;
- cationic dyes having the following general formula: ##STR76## wherein: each R.sup.31, R.sup.32, R.sup.33, and R.sup.34 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- R.sup.35 and R.sup.36 are as defined above for R.sup.33 and R.sup.34 ;
- X is O, S, or NR.sup.37 ;
- Y is N or CR.sup.38 ;
- R.sup.37 and R.sup.38 are as defined above for R.sup.33 ; and wherein
- M- is any suitable anion;
- cationic dyes having the following general formula: ##STR77## wherein: each R.sup.31, R.sup.32, R.sup.33, R.sup.34 and R.sup.40 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group, and wherein any two adjacent R.sup.31, R.sup.32, R.sup.33, or R.sup.34 groups may be connected to form a ring;
- R.sup.39 is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group;
- X is C.dbd.R.sup.48, C(R.sup.38).sub.2, O, S, or NR.sup.37, wherein
- R.sup.37 is as defined above for R.sup.39,
- R.sup.38 is as defined above for R.sup.40 ;
- R.sup.48 is an oxo group, a divalent hydrocarbyl-containing group or a divalent heterocyclic group, and wherein R.sup.48 and R.sup.34 may be connected to form an unsaturated ring, and R.sup.37 and R.sup.34 may be connected to form a ring; and wherein
- M- is any suitable anion; and
- cationic dyes having the following general formula: ##STR78## wherein: each R.sup.42 to R.sup.47 group is independently hydrogen, halogen, a hydrocarbyl-containing group, or a heterocyclic group;
- each R.sup.40, R.sup.41, R.sup.46, and R.sup.47 group is independently hydrogen, a hydrocarbyl-containing group, or a heterocyclic group and wherein any two adjacent R.sup.41 to R.sup.43 and R.sup.44 to R.sup.46 groups may be connected to form a ring;
- n is an integer less than 5; and wherein
- M- is any suitable anion, and wherein said dental impression material exhibits a color change upon curing of at least 10 .DELTA.E* units.
- 57. A silicone composition according to claim 36, wherein said cure-indicating dye is selected from the group consisting of 4-[[4-(Dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 4-[[4-(Diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[4-(Dimethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 4-[[2-methyl-4-(diethylamino)phenyl]imino]-1,4-dihydronaphthalen-1-one; 3-Methoxy-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Methyl-4-[[4-(4-morpholinyl)phenyl]-imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[4-(4-morpholinyl)-phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dimethyl-4-[[4-(4-morpholinyl)-phenyl]imino]-2,5-cyclohexadien-1-one; 2,5-Dichloro-4-[[4-(diethylamino)-phenyl]imino]-2,5-cyclohexadien-1-one; 3-Methoxy-4-[[3-methoxy-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo-N-phenyl-1,4-cyclohexadiene-1-carboxamide; 5-[[4-(Diethylamino)-2-methylphenyl]imino]-8-(5H)-quinolinone; 2,5-Dichloro-4-[[2-methyl-4-(diethylamino)-phenyl]imino]-2,5-cyclohexadiene-1-one; 2,6-Dichloro-4-[[4-(acetamido)phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[4-ethoxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(2-methyl-4-ethoxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dimethyl-4-[4-hydroxy phenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(4-methoxy-1-naphthyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[[4-(benzyloxy)phenyl]imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(2,4-dimethoxyphenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[(4-methoxyphenyl)imino]-2,5-cyclohexadien-1-one; 4-(phenylimino)-2,5-cyclohexadien-1-one; 4-(1-naphthylimino)-2,5-cyclohexadien-1-one; 4-(2-naphthylimino)-2,5-cyclohexadien-1-one; 2,5-Bis(phenylamino)-4(phenylimino)-2,5-cyclohexadien-1-one; 2,5-Dibromo-4-[(2,4-dibromophenyl)imino]-2,5-cyclohexadien-1-one; 2,3,5-Trichloro-4-[(2,4,6-trichlorophenyl)imino]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[4-[4-(dimethylamino)phenyl]-5-phenyl-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Dichloro-4-[4,5-bis(4-hydroxyphenyl)-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Dimethoxy-4-[4,5-bis(2-furyl)-(2H)-imidazol-2-ylidine]-2,5-cyclohexadien-1-one; 2,6-Bis[1,1-(dimethyl)ethyl]-4-[4,5-bis(2-furyl)-(2H)-imidazol-2-ylidene]-2,5-cyclohexadien-1-one; 4-(phenylimino)-2,5-cyclohexadien-1-imine; Mono[(3-methyl-2-(3H)-benzothiazolylidene)hydrazono]2,5-cyclohexadiene-1,4-dione; 4-[(3-Chloro-4-oxo-2,5-cyclohexadien-1-ylidine)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-(3H)-pyrazol-3-one; 4-[(3,5-Dichloro-4-oxo-2,5-cyclohexadien-1-ylidine)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-(3H)-pyrazol-3-one; 3-[(3,5-Dichloro-4-oxo-2,5-cyclohexadien-1-ylidine)amino]-2,5-dihydro-4,5-dimethyl-1-phenylpyrrol-2one; 4-(Phenylsulfonyl)imino-1-[4-[(phenylsulfonyl)imino]-2,5-cyclohexadien-1-ylidenyl]-2,5-cyclohexadiene; 4-[6,6-Bis[(trifluoromethyl)sulfonyl]-1,3,5-hexatrienyl]-N,N-dimethylbenzenamine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2-ethoxy-N,N-dimethylbenzenamine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,5-dimethoxy-N,N-dimethylbenzenamine; 9-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,3,6,7-tetrahydro-(1H,5H)-benzo[ij]quinolizine; 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-2,6-N,N-tetramethyl-benzenamine; 4-[5,5-Bis[(trifluoromethyl)sulfonyl]-2,4-pentadienylidene]-1,4-dihydro-1-methylquinoline; 6,6-Bis[4-(dimethylamino)phenyl]1,3,5-hexatriene-1,1-bis(sulfonylfluoride); 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-N,N-dimethylbenzenamine; and 4-[3-[4-(Dimethylamino)phenyl]-2-propenylidene]-2-phenyl-5(4H)-oxazolone; anionic dyes having the following anions: 5-[5-(1,3-Diethylhexahydro-2,4,6-trioxo-5-pyrimidinyl)-2,4-pentadienylidene]-1,3-diethyl-2,4,6(1H,3H,5H)-pyrimidenetrione; and cationic dyes having the following cations or having the cations of the following cationic dyes: 3H-Indolium, 3-[3-[4-(dimethylamino)phenyl]-2-propenylidene]-1-methyl-2-phenyl; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-[bis(2-chloroethyl)amino]phenyl]azo]-6-methoxy-; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-(diethylamino)phenyl]azo]-6-ethoxy-; Benzothiazolium, 3-(3-amino-3-oxopropyl)-2-[[4-(diethylamino)-2-methylphenyl]azo]-6-ethoxy-; C.I. Basic Blue 68; C.I. Basic Blue 76; C.I. Basic Blue 57; C.I. Basic Blue 60; Benzo[a]phenoxazin-7-ium, 9-(dimethylamino)-; 2-[4,4,-bis[4-dimethylamino)phenyl]-1,3-butadienyl]-1-ethyl quinolinium; 4-[4,4,-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]1-ethyl quinolinium; Naphtho[2,1-d]thiazolium, 2-[4,4-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]-3-ethyl-; 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-phenyl-3-methyl quinoxalinium; Quinolinium, 2-[3-(5-chloro-1,3-dihydro-1,3,3-trimethyl-(2H)-indol-2-ylidene)-1-propenyl]-1-methyl-; Benzothiazolium, 2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methyl-; Benz[cd]indolium, 2-[4-(diethylamino)-2-ethoxyphenyl]-1-ethyl-; 2-[p-(Dimethylamino)styryl]-1,3-dimethylquinoxalinium; 2-[3-(5-chloro-1,3-dihydro-1,3,3-trimethyl-(2H)-indol-2-ylidene)-1-propenyl]-1-methylquinoxalinium; C.I. Basic Blue 40; Benzothiazolium, 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azol-6-methoxy-3-methyl-; Benzothiazolium, 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methyl-; C. I. Basic Blue 42; C. I. Basic Blue 53; 3H-Indolium, 5-chloro-2-[5-(5-chloro-1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1,3-pentadienyl]-1,3,3-trimethyl-; Basic Blue 142; Benz[cd]indolium, 2-[2-(9-ethyl-(9H)-carbazol-3-yl)ethenyl]-1-methyl-; Benz[cd]indolium, 2-[2-[4-(dimethylamino)phenyl]-2-phenylethenyl]-1-methyl-; Benz[cd]indolium, 2-[2,2-bis[4-(dimethylamino)phenyl]ethenyl]-1-methyl-; Benz[cd]indolium, 2-[2-(2,3-dihydro-1-methyl-2-phenyl-1H-indol-3-yl)-2-(2-methylphenyl)ethenyl]-1-methyl-; Pyrimidinium, 4-[5-(2,3-dihydro-1,3-dimethyl-2-oxo-; 4(1H)-pyrimidinylidene)-1,3-pentadienyl]-2,3-dihydro-1,3-dimethyl-2-oxo-; 3H-Indolium, 2-[[3-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)methyl]-5,5-dimethyl-2-cyclohexen-1-ylidene]methyl]-1,3,3-trimethyl-; Benz[cd]indolium, 2-[2-[4-(diethylamino)-2-methylphenyl]ethenyl]-1-methyl-; 3H-Indolium, 3-[3-[4-[(dimethylamino)phenyl]-2-propenylidene]-1-methyl-2-(4-methoxyphenyl)-; 3H-Indolium, 3-[(2,5-dimethyl-1-phenyl-(1H)-pyrrol-3-yl)methylene]-1,2-dimethyl-; 3H-Indolium, 3-[2,5-dimethyl-1-phenyl-(1H)-pyrrol-3-yl)methylene]-1-methyl-2-phenyl-; 2-[2-[2-chloro-4-dimethylamino)phenyl]ethenyl]-1-methylbenz[cd]indolium; C. I. Basic Violet 22; C. I. Basic Red 15; Benz[cd]indolium, 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-; Benz[cd]indolium,2-[2-[4-(dimethylamino)-2-ethoxyphenyl]ethenyl]-1-methyl-; and 3H-Indolium, 2-[1-cyano-4,4-bis[4-(dimethylamino)phenyl]-1,3-butadienyl]-1,3,3-trimethyl-.
- 58. A silicone composition according to claim 36, wherein said cure-indicating dye is selected from the group consisting of 4-[[4-(Dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Chloro-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 4-[[4-(Diethylamino)phenyl]imino]-1,4-dihydronapthalen-1-one; 4-[[4-(Dimethylamino)phenyl]imino]-1,4-dihydronapthalen-1-one; 4-[[2-methyl-4-(diethylamino)phenyl]imino]-1,4-dihydronapthalen-1-one; 3-Methoxy-4-[[2-methyl-4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 2-Methyl-4-[[4-(4-morpholinyl)phenyl]imino]-2,5-cyclohexadien-1-one; 2,5-Dichloro-4-[[4-(diethylamino)phenyl]imino]-2,5-cyclohexadien-1-one; 3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo-N-phenyl-1,4-cyclohexadiene-1-carboxamide; 5-[[4-(Diethylamino)-2-methylphenyl]imino]-8-(5H)-quinolinone; 2,6-Dichloro-4-[[4-(acetamido)phenyl]imino]-2,5-cyclohexadien-1-one; 4-(1-naphthylimino)-2,5-cyclohexadien-1-one; 4-(2-naphthylimino)-2,5-cyclohexadien-1-one; 2,5-Bis(phenylamino)-4(phenylimino)-2,5-cyclohexadien-1-one; 4-[5,5-Bis[(trifluoromethyl)sulfonyl]-2,4-pentadienylidene]-1,4-dihydro-1-methylquinoline; 6,6-Bis[4-(dimethylamino)phenyl]1,3,5-hexatriene-1,1-bis(sulfonylfluoride); 4-[4,4-Bis[(trifluoromethyl)sulfonyl]-1,3-butadienyl]-N,N-dimethylbenzenamine; and 4-[3-[4-(Dimethylamino)phenyl]-2-propenylidene]-2-phenyl-5(4H)-oxazolone.
- 59. A silicone composition comprising:
- a curable silicone polymer containing between 1 and 5,000 dimethyl siloxy bridging groups and at least two vinyl groups;
- a crosslinker compound containing at least two SiH groups and selected from the group consisting of organohydrosilanes, organohydrocyclopolysiloxanes, organohydropolysiloxanes, and branched organohydropolysiloxanes;
- a hydrosilation catalyst, wherein said catalyst comprises platinum and wherein said composition comprises a ratio of platinum to functional groups between 1:2 and 1:1,000; and
- one or more cure-indicating dyes that exhibit a color change within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together, wherein said composition comprises a ratio of SiH groups to functional groups between 1.3:1 and 4:1, and wherein said silicone composition exhibits a color change upon curing of at least 10 .DELTA.E* units.
- 60. A method of monitoring the curing of a curable composition, comprising the steps of:
- mixing a compound having two or more ethylenic functional groups; a crosslinker compound containing at least 2 SiH groups; a hydrosilation catalyst; and a cure-indicating dye that exhibits a color change, in a dye evaluation test, within about 10 minutes at 25.degree. C. when 500 mg of said dye, about 500 ml of dichloromethane, 100 ml of pentamethyldisiloxane, and 10 ml of a hydrosilation catalyst solution having between about 2 and 3 weight percent platinum are mixed together; and
- observing said composition, wherein said composition has a first color before the cure reaction is effected and a second color after the cure reaction has been effected and wherein said first and second colors differ by at least 5 .DELTA.E* units.
- 61. A method of monitoring the curing of a curable composition according to claim 60, wherein the observation step is performed using the human eye.
- 62. A method of monitoring the curing of a curable composition according to claim 60, wherein the second color of said curable composition is visually compared to a reference color standard and wherein the color difference between the reference color standard and the second color of said curable composition is less than 3 .DELTA.E* units.
- 63. A method of monitoring the curing of a curable composition according to claim 60, wherein the first color of said curable composition is visually compared to a reference color standard and wherein the color difference between the reference color standard and the first color of said curable composition is less than 3 .DELTA.E* units.
- 64. A method of monitoring the curing of a curable composition according to claim 62, wherein said reference color standard is selected from the group consisting of printed cards, printed labels, colored paper, colored plastic parts, painted parts, colored ceramic parts, and colored curable compositions.
- 65. A method of monitoring the curing of a curable composition according to claim 60, wherein the observation step is performed using a colorimeter, fluorimeter or spectrophotometer.
- 66. A method of monitoring the curing of a curable composition according to claim 65, wherein said curable composition is a coating composition and wherein said colorimeter, fluorimeter or spectrophotometer is utilized on-line to monitor said color change.
- 67. A method of monitoring the curing of a curable composition according to claim 64, wherein said first and second colors differ by at least 15 .DELTA.E* units.
- 68. A method of monitoring the curing of a curable composition according to claim 60, wherein said curable composition is an impression material.
- 69. A method of monitoring the curing of a curable composition according to claim 68, wherein the color of said impression material is visually compared to a reference color standard selected from the group consisting of printed cards, printed labels, colored plastic parts, painted parts, colored ceramic parts, and colored curable compositions and wherein the color difference between the reference color standard and the second color of said impression material is less than 3 .DELTA.E* units.
Parent Case Info
This application is a continuation in part of application Ser. No. 268,335 filed Jun. 30, 1994, now abandoned.
US Referenced Citations (32)
Foreign Referenced Citations (2)
Number |
Date |
Country |
0225843 |
Jul 1986 |
EPX |
0492830A2 |
Jul 1992 |
EPX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
268335 |
Jun 1994 |
|